Biological battery and biological cathode electrode
11575171 · 2023-02-07
Inventors
Cpc classification
H01M8/16
ELECTRICITY
Y02E60/50
GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
H01M4/8878
ELECTRICITY
H01M12/08
ELECTRICITY
International classification
H01M12/08
ELECTRICITY
H01M4/86
ELECTRICITY
Abstract
A biological cathode and biological battery system for converting carbon feedstock into organic chemicals and producing electrical current is described. The method involves a biological battery system comprising of a reaction vessel and biological cathode electrode. The organic chemicals are processed in a space having at least one anode and at least one cathode with cathode electrode having biologically active material adjacent to at least one layer of the cathode electrode. The material can be a gel, liquid, or solid. This system can be carried out to process organic waste in an environmentally friendly manner.
Claims
1. A biological cathode electrode, having no metallic catalyst, and including: a conductive support layer including a composition selected from the group consisting of carbon, a polymer, and combinations thereof; a contact layer disposed on the conductive support layer and including carbon particles, the carbon particles having a size ranging between 0.1 nm and 500 nm, the contact layer being configured to be in electrical contact with biological components in a medium when the medium is retained in a reaction vessel; and a polymeric binding layer disposed between the conductive support layer and the contact laver, the polymeric binding layer configured to cause adhesion of the contact layer to the conductive support layer while still preserving conductivity between the contact layer and the conductive support layer.
2. The biological cathode electrode of claim 1, wherein the biological cathode is a single piece electrode or stack of multiple sheets assembled as one electrode.
3. The biological cathode electrode of claim 1, wherein the biological cathode is flexible and foldable into different shapes.
4. The biological cathode electrode of claim 1, wherein the contact layer includes porous particles and wherein the porous particles have sizes ranging between 8 nm and 50 nm and a pore size within the porous particles of less than 2 nm.
5. The biological cathode electrode of claim 1, wherein the contact layer includes active biological components that are deposited through either polarization, painting, brushing, filtering, vacuum pressing, coating, soaking, electric deposition, or other deposition, then dried.
6. The biological cathode electrode of claim 5, wherein the coating is deposited is through fluidized bed coating process, one or more liquid layers of coating material, biological components and or carbon particle water solution, are deposited on a solid substrate, porous electrode and subsequently dried to form solid films resulting in a homogenous coating layer of uniform thickness bacteria coated electrode, and wherein the biological components are either loaded into a product basket of a granulator prior to process start or sucked into porous areas when the fluidizing air flow causes suction pressure.
7. The biological cathode electrode of claim 6, wherein the subsequent drying is freeze drying, vacuum drying, spray drying, or fluidized bed drying.
8. The biological cathode electrode of claim 7, wherein protective agents are applied to the active biological components before drying to preserve viability during drying and storage process.
9. The biological cathode electrode of claim 8, wherein the protective agents are sugar and sugar derivatives, such as cryoprotective sugars (trehalose, lactose, sucrose, glucose, maltose), borate ions, and antioxidants, such as ascorbic acid, ammonium compounds.
10. A biological battery system, comprising: a reaction vessel, configured to retain therein a medium containing biological components; a biological cathode electrode, disposed in the reaction vessel, having no metallic catalyst, and including: a conductive support layer including a composition selected from the group consisting of carbon, a polymer, and combinations thereof; a contact layer disposed on the conductive support layer and including carbon particles, the carbon particles having a size ranging between 0.1 nm and 500 nm, the contact layer being configured to be in electrical contact with biological components in a medium when the medium is retained in the reaction vessel; a polymeric binding layer disposed between the conductive support layer and the contact layer, the polymeric binding layer configured to cause adhesion of the contact layer to the conductive support layer while still preserving conductivity between the contact layer and the conductive support layer; and a conductive anode disposed in the reaction vessel, wherein, when in operation, the reaction vessel is open to an ambient air such that air is supplied to the medium and wherein the biological components accept electrons from the cathode.
11. The biological battery system of claim 10, wherein oxidation at the anode is not mediated by the biological components.
12. The biological battery system of claim 10, wherein no anion or cation selective barriers are in the reaction vessel.
13. The biological battery system of claim 10, wherein the medium is in the form of solid, gel or liquid.
14. The biological battery system of claim 10, wherein the biological components include a composition selected from the group consisting of microorganism cells, extracellular polymeric substrates, microorganism secreted compounds, 0.2 um filter filtrated microorganism culture, proteins, enzymes, lipids, amino acid, cofactors, hemes, or cytochromes.
15. The biological battery system of claim 10, wherein the medium contains nano particles or nano substrate.
16. The biological battery system of claim 10, wherein the reaction vessel is a batch system.
17. The biological battery system of claim 10, wherein the reaction vessel is a continuous flow system in which a fresh medium continuously flows into and out of the reaction vessel.
18. The biological battery system of claim 10, wherein the anode is a single piece electrode or stack of multiple sheets assembled as one electrode.
19. The biological battery system of claim 10, wherein the anode is flexible and foldable into different shapes.
Description
BRIEF DESCRIPTION OF THE DRAWINGS
(1) The objects and features of the invention can be better understood with reference to the drawings described below, and the claims.
(2)
(3)
(4)
(5)
(6)
DETAILED DESCRIPTION
(7) The Cathodic Microorganism
(8) The invention can be described specifically and illustrated by presenting one or more preferred embodiments in the paragraphs that follow. At least one preferred embodiment of the present invention provides for incorporating into an electrode one or more strains of bacteria that can enact the conversion of carbon dioxide into useful multi-carbon compounds with higher efficiency under aerobic conditions and suitable electrochemical conditions.
(9) In at least one embodiment, the reaction medium can be configured to contain carbon dioxide as a source of carbon and to be oxidized; a source of electrical energy, the source of electrical energy connected to the cathode contact terminal; and the biological material adjacent to at least one surface of the cathode electrode by way of the reaction medium.
(10) In addition, the present invention can be used as cathode material in many devices. Modifications to the conditions can result in the generation of higher current density. The Microbial Fuel Cell can comprise a reaction vessel having an anode electrode/stack of anode electrodes and a cathode electrode/stack of cathode electrodes disposed therein. At least one embodiment of the invention provides further for no ion exchange membrane or other separators to be placed in between the anode and cathode electrode, the cathode electrode having biologically active material adjacent to at least one surface of the cathode electrode and in electrical communication therewith, the reaction vessel configured to contain a working fluid therein; and a reaction medium in contact with the cathode electrode and the anode electrode.
(11) Depending on the specific microorganism(s) utilized, variables to be considered in forming products include, for example, among others, without limitation: nutrient constituents and concentrations, medium, pressure, temperature, gas flow rate, liquid flow rate, reaction pH, agitation rate (if utilizing a Continuously Stirred Tank Reactor), inoculums concentration, maximum substrate (introduced gas) concentrations to avoid inhibition, and maximum product concentrations to avoid inhibition.
(12) The present invention provides, in at least one embodiment, a process for producing acetic acid, comprising: providing a continuous flow of air and/or a gas comprising carbon dioxide into a bioreactor, said bioreactor containing anode and cathode electrode, an aqueous nutrient medium and the bacterium on the cathode side; directing a flow of the aqueous medium into the cathode side; and converting the gas in the medium using the bacterium at a pH around neutral under conditions that permit converting the gas to the acetic acid.
(13) In one preferred embodiment the acetic acid can be recovered from the aqueous phase in a separate vessel or vessels, utilizing a suitable recovery process. Examples of recovery processes include extraction, distillation or combinations thereof, or other efficient recovery processes. The bacteria are removed from the aqueous phase and recycled to avoid toxicity and maintain high cell concentrations, thus maximizing reaction rates. Cell separation, if desired, is accomplished by centrifugation, membranous ultrafiltration, or other techniques.
(14) The invention also provides, in an alternative aspect, one or more pure cultures of the microorganisms can be describable.
(15) Setups of the Biological Reactor
(16) A bioreactor having a reaction vessel with an anode electrode and a cathode electrode disposed therein, the anode electrode having at least one surface and an anode electrical contact terminal, the cathode electrode having at least one surface and a cathode electrical contact terminal, the cathode electrode having biologically active material adjacent to at least one modified surface of the cathode electrode and in electrical communication therewith, the reaction vessel configured to contain a working fluid for anode and cathode having mobile ions, a reaction medium in contact with the cathode electrode and the anode electrode, the reaction medium configured to contain dissolved carbon dioxide as a source of carbon for cathode, a batch or a flow of medium into and out of the reactor, a continuous access or supply of air into the cathode side, such that the gas mixes dissolve into the medium, and maintaining pH around neutral and maintaining other conditions appropriate for permitting the bacterium to catalyze the oxidation reaction with oxygen as electron acceptor. The biological system can be flow through system, in which a medium with biological active material flow through the battery reaction vessel and flow out from the nearby cathode electrode area. The medium can contain nano particles or nano substrates. The anode and cathode of the battery may be flexibly folded or manipulated into different shapes and dimensions. Both anode and cathode can be in the format of single piece electrode or stack of multiple sheets assembled as one electrode. The medium can be in the form of liquid, gel or solid. In one embodiment, the active cathodic microorganisms are deposited on the surface of the electrode through either painting, brushing, coating, soaking, electric deposition or other deposition method to the support layer (electrode) in binding solution then dry. One embodiment of a coating process is through fluidized bed coating process, one or more liquid layers of coating material, bacteria culture and or carbon particle water solution or TEFLON® solution, are deposited on a solid substrate, porous electrode and subsequently dried to form solid films resulting in a homogenous coating layer of uniform thickness bacteria coated electrode. The cells are either loaded into the product basket of the granulator prior to process start or sucked into the porous when the fluidizing air flow causes suction pressure. Drying processes are through either freeze drying, vacuum drying, spray drying, or fluidized bed drying. The drying processes are through either freeze drying, vacuum drying, spray drying, or fluidized bed drying. The protective mechanisms/agents such as sugar and sugar derivatives, such as cryoprotective sugars (trehalose, lactose, sucrose, glucose, maltose), borate ions, and antioxidants, such as ascorbic acid, ammonium Compounds are applied to the active biological components before drying to preserve their viability during drying and storage process.
(17) In at least one preferred embodiment, a power source, such as a potentiostat, can be used to set up a three-electrode configuration during acetic acid generation (as depicted in
(18) In a further embodiment, a working fluid having mobile ions therein is a source of a chemical species configured to be oxidized. In yet a further embodiment, the apparatus further comprises a control module configured to control a selected one of an electrical potential applied between the cathode electrode and the anode electrode, and an electrical current caused to flow between the cathode electrode and the anode electrode. In an additional embodiment, the apparatus further comprises a third electrode having a third electrical contact terminal in electrical communication with the control module, the third electrode configured to provide a reference potential to the cathode electrode.
(19) Other objects and further scope of the applicability of the present invention will become apparent from the further detailed description that follows, taken in conjunction with the accompanying drawings, wherein like parts are designated by like reference numerals. The following specific examples of one or more preferred embodiments are submitted to illustrate but not to limit the present invention.
Examples
(20)
(21) A more preferred range is between 100 ml and 1 m.sup.3. The bioreactor is preferably a batch reactor or chemostat preferably at a flow rate between 1 ml/min to 100 ml/min, and more preferably a flow rate between 1 ml/min and 10 ml/min.
(22) For both cases, anode and cathode electrodes are preferred to be configured with the same size facing to each other with the membrane constructed in the middle. The preferred size of the electrode is according to the volume of the reactor. For example, in a 30.8 m.sup.3 reactor the size of electrode is preferably about 3.35 m×3.35 m.
(23) Continuing to refer to
(24) Effluent water can be released via effluent water outlet 13, and can be controlled at normal pressure with valves. A separation and purification tank 9 can be attached by piping or other means to the extraction tank 12. At tank 9, the product can be further purified with less water content (one example vendor can be distillation columns and absorption columns from Titanium Fabrication Corporation). Pumps can be added at influent and effluent tank, as well as between each tank if necessary to assist liquid transportation.
(25) Continuing to refer to
(26) Effluent water can be released via effluent water outlet 13, and can be controlled at normal pressure with valves. A separation and purification tank 9 can be attached by piping or other means to the extraction tank 12. At tank 9, the product can be further purified with less water content (one example vendor can be distillation columns and absorption columns from Titanium Fabrication Corporation). Pumps can be added at influent and effluent tank, as well as between each tank if necessary to assist liquid transportation.
(27) Cooling is preferred for the safety of transportation. Cooling tank 10 is connected by piping to separation tank 9. Cooling is preferred to a temperature lower than 30° C. Stainless steel of ASTM 316 or 321 grade or equivalent is suitable for cooling and storage of all grades of acetic acid and its salts. The material of tanks and pipes are preferably stainless steel. In some embodiments, aluminum of minimum 99.5% purity can be used for the storage of glacial acetic acid. The temperature control of the acid must be more precise when aluminum is used rather than stainless steel, since above 30° C. the corrosion rate increases sharply, with the formation of aluminum acetate. A product collection port can be connected to the cooling tank 10, or in some embodiments can be connected directly to the purification tank 9, or to the distillation tank 12, and a transportation or storage port 14 enables product to be removed to a transportation vehicle or another storage venue, such as storage tank as mentioned above.
(28) In accordance with an exemplary embodiment of the present invention and as shown in
(29) The carbon dioxide/air gases I are continuously introduced into the feedstock mixing tank 3. The gas is preferably retained in the bioreactor 8 at normal pressure or higher pressure for maximizes efficiency of the process. In one embodiment, normal pressure is preferred for maintaining pressure in the system consistent.
(30) In the biological reactor 8, bacteria inoculums are mixed with influent feedstock. Bacteria cells attach on and obtain electrons from the cathode electrode through augmentation during polarization at desired potential. In the reactor, a reference electrode is placed near the cathode. Cathode, anode and reference electrodes are connected with power source, such as a potentiostat (such as available from Gamry Instruments, Warminster, Pa.). For different microorganisms, the poise potential is different. For example, a poise potential for Geobacter suljurreducens, KN400 is −400 mV. Under different operation conditions in other embodiments of the inventions, the preferred poise potential for the microorganism may vary. In one embodiment, the active cathodic microorganisms are deposited on the surface of the electrode through either painting, brushing, coating, soaking, electric deposition or other deposition method to the support layer (electrode) in binding solution then dry. One embodiment of a coating process is through fluidized bed coating process, one or more liquid layers of coating material, bacteria culture and or carbon particle water solution or TEFLON® solution, are deposited on a solid substrate, porous electrode and subsequently dried to form solid films resulting in a homogenous coating layer of uniform thickness bacteria coated electrode. The cells are either loaded into the product basket of the granulator prior to process start or sucked into the porous when the fluidizing air flow causes suction pressure. Drying processes are through either freeze drying, vacuum drying, spray drying, or fluidized bed drying. The drying processes are through either freeze drying, vacuum drying, spray drying, or fluidized bed drying. The protective mechanisms/agents such as sugar and sugar derivatives, such as cryoprotective sugars (trehalose, lactose, sucrose, glucose, maltose), borate ions, and antioxidants, such as ascorbic acid, ammonium Compounds are applied to the active biological components before drying to preserve their viability during drying and storage process.
(31) Acetic acid (and/or its salt solutions) is generated in the cathode side of the bioreactor 8 and can flow into the distillation and extraction tank through a pump at flow rates between 0.1 ml/min and 10 ml/min, preferably at 0.5 ml/min. Higher flow rates can be used as needed to replace or discharge the batch solution after a period of time for batch mode. Pumps in the system can be present to assist constant flow rate when the system is set at chemostat mode. At cooling tank 10, purified acidic acid or its salts will be cooled and condensed by water. The temperature will be controlled at below 30° C., preferably at room temperature. Then it will be collected and transported through port 14 and 15. For example collected and transport using stainless steel storage tank (Northeast Fluid Control, Inc.).
(32)
(33) Referring to
(34) Still referring to
(35) In at least one even more preferred embodiment of the invention, referring still to
(36) Referring now to
(37) In
(38) Still referring to
(39) In the processes described hereinabove and depicted in
(40) Still referring to
(41) In one embodiment, the active cathodic microorganisms/biological material are deposited on the surface of the electrode through either painting, brushing, filtering, flow through, vacuum pressing, coating, soaking the support layer (electrode) in binding solution then dry. One embodiment of a coating process is through fluidized bed coating process, one or more liquid layers of coating material, bacteria culture and carbon particle water solution or TEFLON® solution, are deposited on a solid substrate, porous electrode and subsequently dried to form solid films resulting in a homogenous coating layer of uniform thickness bacteria coated electrode. The cells are either loaded into the product basket of the granulator prior to process start or sucked into the porous when the fluidizing air flow causes suction pressure. Drying processes are through either freeze drying, vacuum drying, spray drying, or fluidized bed drying. Protective mechanisms are applied to the microorganisms before drying to preserve their viability during drying and storage process. The protection agents added including sugar and sugar derivatives, such as cryoprotective sugars (trehalose, lactose, sucrose, glucose, maltose), borate ions, and antioxidants, such as ascorbic acid, Ammonium Compounds.
(42) Referring again to
(43) In one embodiment, a biocathode metal-air battery cell contains a reaction vessel having an anode electrode and a cathode electrode disposed therein, anode and cathode are isolated by an ion exchange membrane or a separation membrane. The anode electrode can be metal, such as, lithium, magnesium, zinc, sodium, magnesium, ion, aluminum, calcium, potassium, manganese, chromium, having at least one surface and an anode electrical contact terminal, the cathode electrode having at least one surface and a cathode electrical contact terminal, the biological cathode electrode having biologically active material adjacent to at least one of the contact layers of the cathode electrode and in electrical communication therewith, the reaction vessel configured to contain a working fluid having mobile ions therein; a reaction medium in contact with the cathode electrode and the anode electrode, the reaction medium, configured to contain dissolved carbon dioxide and air. Carbon dioxide may serve as a source of carbon to the microorganisms; the biologically active material adjacent to at least one contact layer of the cathode electrode by way of the reaction medium.
(44) In one embodiment, a biocathode fuel cell system, comprising a reaction vessel having an anode electrode and a cathode electrode disposed therein, anode and cathode. The anode electrode can be metal, such as, lithium, magnesium, zinc, sodium, magnesium, ion, aluminum, calcium, potassium, manganese, chromium, organic compounds or other compounds as fuel, having at least one surface and an anode electrical contact terminal, the cathode electrode having at least one surface and a cathode electrical contact terminal, the cathode electrode having biologically active material adjacent to at least one surface of contact layer of the cathode electrode and in electrical communication therewith, the reaction vessel configured to contain a working fluid; a reaction medium in contact with the cathode electrode and the anode electrode, the reaction medium, configured to contain dissolved carbon dioxide and air. The air is continuously supplied and the metals are consumed as fuel. Carbon dioxide may serve as a source of carbon to the microorganisms; The biologically active material adjacent to at least one contact layer of the cathode electrode by way of the reaction medium.
(45) TABLE-US-00001 TABLE 1 Comparison of the current output of aerobic facultative biocathode. Dura- Polari- LPP Current dens. tion Cathode zation Cul- v. Source (A/m2) (day) Material method ture SHE(V) 1. 0.46 nc 12 SS CP MC −0.156 2. 0.6 nc na GF CP MC −0.001 3. 0.37 V.C not ind SS PC PC −0.32 4. 0.50 nc not ind SS PC PC −0.001 5. 0.92 V.C >11 GR CP PC −0.351 6. 7.5 V.C >11 CM CP PC −0.351 7. exp > 7.5 v.c >11 CPM CP PC −0.351 Where sources are 1. Bergel et al., 2005; 2. Erable B., Bergel et al., 2010; 3. Rabaey et al., 2008; 4. Vandecandelaere et al., 2008; 5. Zhang, P., et al, 2011 (manuscript); 6. Zhang, P., 2012; 7. Zhang, P., et al (pending). Current density: nc = no control; v.c. = versus control. Cathode material: SS = stainless steel, GF = graphite felt (no collector), GR = Graphite Rod, CM = Carbon material, CPM = Compatible material. Polarization method: CP = Constant Polarization, PC = Polarization curve (lmV/s). Culture: MC = Mix culture, PC = Pure culture. LPP = lowest polarization potential.
Bacteria that can be Used in Various Embodiments
(46) Anaerobic bacteria which are known to convert carbon monoxide and water or hydrogen and carbon dioxide into alcohols and acids and acid salts include Acetobacterium kivui, A. woodii, Clostridium acelicum, Butyribacterium methylotrophicum, C. acetobutylicum, C. formoaceticum, C. kluyveri, C. thermoaceticum, C. thermocellum, C. thermohydrosuljuricum, C. thermosaccharolyticum, Eubacterium limosum, C. jungdahlii PETC and Peptostreptococcus productus. Acetobacterium woodii and Acetoanaerobium noterae produce acetate from H.sub.2 and CO.sub.2; but, in addition to acetate, A. noterae produces some propionate and butyrate. Another chemolithotrophic bacteria, Clostridium aceticum, produces acetate from CO.sub.2 using a glycine decarboxylase pathway.
(47) By mixed strains, it is meant a mixed culture of two or more bacteria. This mixed strain, when utilized in the process described herein, produces acetic acid under aerobic or anaerobic conditions. It may also be applied to biocathode utilized to produce other organic acids or salts thereof, alcohols, hydrogen, SCP or other product, such as electricity etc.
(48) In the development of the present invention, new strains of facultative bacteria have been isolated which cause this conversion with high efficiency as compared to other known bacteria as shown in Table I (and
(49) Thus, it will be appreciated that as a result of the present invention, a high efficient, cost effective, biological cathode electrode material provides board applications in acetic acid generation, enhancing performance of microbial fuel cell, biological battery, fuel cell etc.
(50) Thus, as a result of the present invention, a highly effective improved process for converting carbon dioxide to acetic acid, oxalic acid, 2-oxobutyrate or its salts is provided by which the principal objective, among others, is completely fulfilled.
(51) In accordance with the present invention it is now possible to produce valuable acetic acid and acetate salts, oxalic acid, 2-oxobutyrate, not only reducing consumption of valuable chemical feedstock, but also removing hazardous atmospheric pollutants from the carbon dioxide gas streams of industries. Previous processes to derive these chemicals biologically were based on fermentation of sugars.
(52) The cultivation and operational cost of the invention is lower with broader application and commercialization potential.
(53) In accordance with the present invention, acetic acid and other useful compounds are (is) produced from the biological consumption of carbon dioxide, thereby reducing environmental global warming gas content, at the same time saving energy and chemical feedstock.
(54) MFC as a renewable energy technique, if it can be scaled up for commercialization, will generate tremendous revenue for multiple industries. Today, more than 16,000 municipal wastewater treatment facilities (WWTFs) are in operation in the United States. Total cost of electricity bill of WWTFs is about 4 billion dollars per year. An enhanced cathode according to the invention makes the MFC an ideal technology for BOD removal and renewable bioenergy generation for wastewater treatment plant. Also, for the $1.5 billion marine underwater power supply market, there is a need to have more sustainable and less toxic power supply solution. An embodiment of an enhanced biocathode according to the invention can continuously generate energy in long term without toxicity issues. With such a biocathode, having 10 times higher performance than before enhancement and 40 times better performance than carbon electrode, the commercialization of Bio-cathode MFC in multiple industries is possible. MFC as a clean energy technique will benefit the sustainable development of our society in long run.
(55) According to a 2005 estimate, the worldwide battery industry generates US$48 billion in sales each year, with 6% annual growth. The global metal air batteries market is expected to grow to nearly $1.7 billion by 2018, with a five-year compound annual growth rate (CAGR) of 31%. Hearing aid devices, the fastest-growing segment, is moving at a steady 3.7% CAGR. In 2012, the fuel cell and hydrogen energy industry was expected to produce $785 million in revenue, according to Pike Research.
(56) It is contemplated and will be apparent to those skilled in the art from the preceding description and accompanying drawings that modifications and/or changes may be made in the illustrated embodiments without departure from the present invention. Accordingly, it is expressly intended that the foregoing description and accompanying drawings are illustrative of preferred embodiments only, and are not limiting, and that the scope of the present invention be determined by reference to the appended claims.